Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis

Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N et al (2008) Amyloid-β dynamics correlate with neurological status in the injured human brain. Science 321:1221–1224. https://doi.org/10.1126/science.1161591 Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O (2012) Cerebrospinal fluid levels of β-amyloid 1–42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Arch Gen Psychiatry 69:98–106. https://doi.org/10.1001/archgenpsychiatry.2011.155 Capetillo-Zarate E, Gracia L, Yu F, Banfelder JR, Lin MT, Tampellini D et al (2011) High-resolution 3D reconstruction reveals intra-synaptic amyloid fibrils. Am J Pathol 179:2551–2558. https://doi.org/10.1016/j.ajpath.2011.07.045 Christensen DZ, Bayer TA, Wirths O (2009) Formic acid is essential for immunohistochemical detection of aggregated intraneuronal Aβ peptides in mouse models of Alzheimer’s disease. Brain Res 1301:116–125. https://doi.org/10.1016/j.brainres.2009.09.014 Cras P, Kawai M, Lowery D, Gonzalez-DeWhitt P, Greenberg B, Perry G (1991) Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci USA 88:7552–7556 D’Andrea MR, Nagele RG, Wang H-Y, Peterson PA, Lee DHS (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer’s disease. Histopathology 38:120–134. https://doi.org/10.1046/j.1365-2559.2001.01082.x Fritschi SK, Langer F, Kaeser SA, Maia LF, Portelius E, Pinotsi D et al (2014) Highly potent soluble amyloid-β seeds in human Alzheimer brain but not cerebrospinal fluid. Brain 137:2909–2915. https://doi.org/10.1093/brain/awu255 Giesers NK, Wirths O (2020) Loss of hippocampal calretinin and parvalbumin interneurons in the 5XFAD mouse model of Alzheimer’s disease. ASN Neuro 12:1759091420925356. https://doi.org/10.1177/1759091420925356 Gouras GK, Tsai J, Naslund J, Vincent B, Edgar M, Checler F et al (2000) Intraneuronal Abeta42 accumulation in human brain. Am J Pathol 156:15–20 Greenwood SM, Mizielinska SM, Frenguelli BG, Harvey J, Connolly CN (2007) Mitochondrial dysfunction and dendritic beading during neuronal toxicity*. J Biol Chem 282:26235–26244. https://doi.org/10.1074/jbc.M704488200 Gusel’nikova VV, Korzhevskiy DE (2015) NeuN as a neuronal nuclear antigen and neuron differentiation marker. Acta Naturae 7:42–47 Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O et al (2016) CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol 3:154–165. https://doi.org/10.1002/acn3.274 Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S et al (2012) A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature 488:96–99. https://doi.org/10.1038/nature11283 Kandalepas PC, Sadleir KR, Eimer WA, Zhao J, Nicholson DA, Vassar R (2013) The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta Neuropathol 126:329–352. https://doi.org/10.1007/s00401-013-1152-3 Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD et al (2000) Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor protein-transgenic mice. J Neurosci 20:3606–3611. https://doi.org/10.1523/JNEUROSCI.20-10-03606.2000 Kayed R, Head E, Sarsoza F, Saing T, Cotman CW, Necula M et al (2007) Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol Neurodegener 2:18. https://doi.org/10.1186/1750-1326-2-18 Kobro-Flatmoen A, Nagelhus A, Witter MP (2016) Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer’s disease. Neurobiol Dis 93:172–183. https://doi.org/10.1016/j.nbd.2016.05.012 Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL et al (2004) Synaptic targeting by Alzheimer’s-related amyloid β oligomers. J Neurosci 24:10191–10200. https://doi.org/10.1523/JNEUROSCI.3432-04.2004 Langer F, Eisele YS, Fritschi SK, Staufenbiel M, Walker LC, Jucker M (2011) Soluble Aβ seeds are potent inducers of cerebral β-amyloid deposition. J Neurosci 31:14488–14495. https://doi.org/10.1523/JNEUROSCI.3088-11.2011 Lazarov O, Lee M, Peterson DA, Sisodia SS (2002) Evidence that synaptically released β-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 22:9785–9793. https://doi.org/10.1523/JNEUROSCI.22-22-09785.2002 Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E et al (2006) Exogenous induction of cerebral ß-amyloidogenesis is governed by agent and host. Science 313:1781–1784. https://doi.org/10.1126/science.1131864 Mori C, Spooner ET, Wisniewsk KE, Wisniewski TM, Yamaguch H, Saido TC et al (2002) Intraneuronal Abeta42 accumulation in Down syndrome brain. Amyloid 9:88–102 Mukaetova-Ladinska EB, Harrington CR, Roth M, Wischik CM (1993) Biochemical and anatomical redistribution of tau protein in Alzheimer’s disease. Am J Pathol 143:565–578 Oddo S, Caccamo A, Smith IF, Green KN, LaFerla FM (2006) A dynamic relationship between intracellular and extracellular pools of Aβ. Am J Pathol 168:184–194 Olsson TT, Klementieva O, Gouras GK (2018) Prion-like seeding and nucleation of intracellular amyloid-β. Neurobiol Dis 113:1–10. https://doi.org/10.1016/j.nbd.2018.01.015 Palmqvist S, Schöll M, Strandberg O, Mattsson N, Stomrud E, Zetterberg H et al (2017) Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun. https://doi.org/10.1038/s41467-017-01150-x Pensalfini A, Albay R, Rasool S, Wu J, Hatami A, Arai H et al (2014) Intracellular amyloid and the neuronal origin of Alzheimer neuritic plaques. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2014.07.011 Roberts BR, Lind M, Wagen AZ, Rembach A, Frugier T, Li Q-X et al (2017) Biochemically-defined pools of amyloid-β in sporadic Alzheimer’s disease: correlation with amyloid PET. Brain 140:1486–1498. https://doi.org/10.1093/brain/awx057 Rosen RF, Fritz JJ, Dooyema J, Cintron AF, Hamaguchi T, Lah JJ et al (2012) Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats. J Neurochem 120:660–666. https://doi.org/10.1111/j.1471-4159.2011.07551.x Sadleir KR, Kandalepas PC, Buggia-Prévot V, Nicholson DA, Thinakaran G, Vassar R (2016) Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer’s disease. Acta Neuropathol 132:235–256. https://doi.org/10.1007/s00401-016-1558-9 Sheng JG, Price DL, Koliatsos VE (2002) Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Aβ amyloidosis. J Neurosci 22:9794–9799. https://doi.org/10.1523/JNEUROSCI.22-22-09794.2002 Stöhr J, Watts JC, Mensinger ZL, Oehler A, Grillo SK, DeArmond SJ et al (2012) Purified and synthetic Alzheimer’s amyloid beta (Aβ) prions. PNAS 109:11025–11030. https://doi.org/10.1073/pnas.1206555109 Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA et al (2004) Oligomerization of Alzheimer’s β-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24:3592–3599. https://doi.org/10.1523/JNEUROSCI.5167-03.2004 Takahashi RH, Capetillo-Zarate E, Lin MT, Milner TA, Gouras GK (2013) Accumulation of intraneuronal β-amyloid 42 peptides is associated with early changes in microtubule-associated protein 2 in neurites and synapses. PLoS ONE 8:e51965. https://doi.org/10.1371/journal.pone.0051965 Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H et al (2002) Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 161:1869–1879 Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E et al (2015) Clearance systems in the brain—implications for Alzheimer disease. Nat Rev Neurol 11:457–470. https://doi.org/10.1038/nrneurol.2015.119 Van Cauwenberghe C, Van Broeckhoven C, Sleegers K (2016) The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med 18:421–430. https://doi.org/10.1038/gim.2015.117 Velasco ME, Smith MA, Siedlak SL, Nunomura A, Perry G (1998) Striation is the characteristic neuritic abnormality in Alzheimer disease. Brain Res 813:329–333. https://doi.org/10.1016/S0006-8993(98)01034-8 Walker LC, Callahan MJ, Bian F, Durham RA, Roher AE, Lipinski WJ (2002) Exogenous induction of cerebral beta-amyloidosis in betaAPP-transgenic mice. Peptides 23:1241–1247. https://doi.org/10.1016/s0196-9781(02)00059-1 Walker LC, Schelle J, Jucker M (2016) The prion-like properties of amyloid-β assemblies: implications for Alzheimer’s disease. Cold Spring Harb Perspect Med. https://doi.org/10.1101/cshperspect.a024398 Welikovitch LA, Do Carmo S, Maglóczky Z, Szocsics P, Lőke J, Freund T et al (2018) Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex. Acta Neuropathol 136:901–917. https://doi.org/10.1007/s00401-018-1922-z Willén K, Edgar JR, Hasegawa T, Tanaka N, Futter CE, Gouras GK (2017) Aβ accumulation causes MVB enlargement and is modelled by dominant negative VPS4A. Mol Neurodegener 12:61. https://doi.org/10.1186/s13024-017-0203-y Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G et al (2001) Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci Lett 306:116–120. https://doi.org/10.1016/S0304-3940(01)01876-6 Witter MP (2007) The perforant path: projections from the entorhinal cortex to the dentate gyrus. In: Scharfman HE (ed) Progress in brain research. Elsevier, Amsterdam, pp 43–61 Yang AJ, Chandswangbhuvana D, Shu T, Henschen A, Glabe CG (1999) Intracellular accumulation of insoluble, newly synthesized Aβn-42 in amyloid precursor protein-transfected cells that have been treated with Aβ1–42. J Biol Chem 274:20650–20656. https://doi.org/10.1074/jbc.274.29.20650 Ye L, Fritschi SK, Schelle J, Obermüller U, Degenhardt K, Kaeser SA et al (2015) Persistence of Aβ seeds in APP null mouse brain. Nat Neurosci 18:1559–1561. https://doi.org/10.1038/nn.4117 Ye L, Hamaguchi T, Fritschi SK, Eisele YS, Obermüller U, Jucker M et al (2015) Progression of seed-induced Aβ deposition within the limbic connectome. Brain Pathol 25:743–752. https://doi.org/10.1111/bpa.12252 Ziegler-Waldkirch S, d’Errico P, Sauer J, Erny D, Savanthrapadian S, Loreth D et al (2018) Seed-induced Aβ deposition is modulated by microglia under environmental enrichment in a mouse model of Alzheimer’s disease. EMBO J 37:167–182. https://doi.org/10.15252/embj.201797021